People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Biotechnology, Pharmaceuticals, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tarveda Therapeutics, Inc. | — | Biotechnology | Series B | $127.4M | $141.7M | 2012 |
| NexImmune, Inc. | — | Biotechnology | Series B | $35.0M | $308.3M | 2014 |
| Zosano Pharma Corp | — | Pharmaceuticals | Series A | $29.7M | $233.4M | 2013 |
| Predictive Biosciences, Inc | — | Biotechnology | Series B | $26.8M | $1.0B | 2010 |
| AgeneBio, Inc. | — | Biotechnology | Series A | $13.8M | $18.1M | 2013 |
| Edge Total Intelligence Inc. | — | AI / ML | Series A | $9.6M | $25.0M | 2025 |
James Barrett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Barrett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert S Langer | 2 | 14 |
| M. James Barrett | 2 | 6 |
| Vikram Lamba | 2 | 4 |
| Robert Langer | 1 | 36 |
| John Walker | 1 | 17 |
| Michael Greeley | 1 | 15 |
| Peter Barton Hutt | 1 | 14 |
| Robert Spiegel | 1 | 8 |
| Brian Roberts | 1 | 7 |
| John Palmer | 1 | 6 |
| Kenneth Carter | 1 | 6 |
| Sheri Rempel | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Kleanthis Xanthopoulos | 1 | 4 |
| Jay Moorin | 1 | 4 |
| Dennis Ausiello | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Christopher Krueger | 1 | 4 |
| Omid Farokhzad | 1 | 4 |
| Omid C. Farokhzad | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.